Anti-lymphocyte antibodies late in the course of pediatric renal transplantation

Pediatric Nephrology

Volumn 13, Issue 3, 1999, Pages 192-194

  Butani, Lavjay ^a   Polinsky, Martin S ^a   Kaiser, Bruce A ^a   Baluarte, H J ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Anti thymocyte globulin; OKT3; Transplantation

Indexed keywords

CREATININE; LYMPHOCYTE ANTIBODY; OKT 3;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MUROMONAB-CD3; TIME; TREATMENT OUTCOME;

EID: 0032914706     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050590     Document Type: Article

References (12)

1. Kung PC, Goldstein G, Reinherz EL, Schlossman SF (1979) Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347-349
2. VanWauve JP, DeMay JR, Goosens JG (1980) OKT3: a monoclonal anti-human T lymphocyte antibody with potent mytogenic properties. J Immunol 124:2708-2713
3. Ortho Multi-Center Transplant Study Group (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313:337-342
4. Swinnen LJ, Constanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Piffare R, Fisher RI (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323:1723-1728
5. Goldstein G, Fuccello AJ, Norman DJ, Shield CF, Colvin RB, Cosimi AB (1986) OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3. Transplantation 42:507-510
6. Norman DJ, Shield CF, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M (1988) Effectiveness of second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Transplantation 46:523-529
7. Hardy MA, Nowygrod R, Elberg A, Appel G (1980) Use of ATG in treatment of steroid resistant rejection. Transplantation 29:162-164
8. Shield CF, Norman DJ, Marlett P, Fucello AJ, Goldstein G (1987) Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin. Nephron 46 [Suppl 1]:48-51
9. Kimball JA, Pescovitz MD, Book BK, Norman DJ (1995) Reduced human IgG anti-atgam antibody formation in renal transplant recipients receiving mycophenolate mofetil. Transplantation 60:1379-1383
10. Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM (1988) Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) 67:40-57
11. Wechter W, Brodie JA, Morrell RM, Rafi M, Schultz JR (1979) Antithymocyte globulin (ATGAM) in renal allograft recipients. Transplantation 28:294-302
12. Schwartz G, Brion L, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590